Literature DB >> 1793216

Cytokine release by peripheral blood lymphocytes targeted with bispecific antibodies, and its role in blocking tumor growth.

D M Segal1, J H Qian, S M Andrew, J A Titus, D Mezzanzanica, M A Garrido, J R Wunderlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1793216     DOI： 10.1111/j.1749-6632.1991.tb33459.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells.

Authors:  B J Kroesen; A ter Haar; H Spakman; P Willemse; D T Sleijfer; E G de Vries; N H Mulder; H H Berendsen; P C Limburg; T H The
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

2.  Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

Authors:  B J Kroesen; J Buter; D T Sleijfer; R A Janssen; W T van der Graaf; T H The; L de Leij; N H Mulder
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.